This descriptive study was accomplished on 83 K. pneumoniae strains isolated from two hospitals in Tehran, Iran. Antibiotic susceptibility tests were performed by disc diffusion and broth microdilution methods. ESBLs, MBL, Amp-C, and KPC producing strains were detected by phenotypic confirmatory test, combination disk diffusion test (CDDT), Amp-C detection kit, and modified Hodge test, respectively. OXA-48, NDM-1, and CTX-M-15 genes were detected by PCR and sequencing methods. The outer membrane porins such as OmpK35 and OmpK36 were analysed by SDS-PAGE, PCR, and sequencing methods. From 83 K. pneumoniae isolates, 48 (57.5%), 3 (3.5%), 23 (28%), and 5 (6%) were ESBL, MBL, Amp-C, and KPC positive, respectively. The CTX-M-15 gene was detected in 30 (62.5%) and OXA-48 gene was found in 2 (4.1%) of the 48 ESBL-producing isolates. Two isolates harboured both OXA-48 and CTX-M-15; NDM-1 gene was not detected in this study. Outer membrane porin, OmpK35, was detected in 30 (62.5%) of 48 ESBL-producing isolates while OmpK36 was found in 35 (72.91%) of 48 ESBL-producing isolates. In this study, fosfomycin and tigecycline were more effective than other antibiotics. The high prevalence of -lactamase-producing K. pneumoniae detected in this study is of great concern, which requires infection control measures including antibacterial management and identification of -lactamases-producing isolates.
Introduction
Carbapenems currently represent the antibiotics of choice for treatment of serious infections caused by multidrugresistant strains of K. pneumoniae which produce extendedspectrum -lactamases (ESBLs) [1] . Carbapenem resistance in K. pneumoniae is based on various mechanisms that may involve carbapenemase production, upregulation of efflux pumps, or loss of porins, including OmpK35, OmpK36, and OmpK37. Some commonly detected carbapenemases are Klebsiella pneumoniae carbapenemase(KPC), New Delhi metallo--lactamase-1 (NDM-1), and OXA-48-type enzymes whose respective genes are located on plasmids that enable their transfer between different gram-negative bacteria species [2] . The Ambler class D -lactamase OXA-48, which hydrolyzes penicillins and imipenem and extended-spectrum cephalosporins, was first reported from a carbapenemresistant K. pneumoniae isolate from Turkey. Outbreaks of OXA-48-producing K. pneumoniae and other isolates have been reported from various regions of Turkey and once in the United Kingdom. Subsequently, single isolates of OXA-48-producing K. pneumoniae have been reported from Belgium, Lebanon, the United Kingdom, Morocco, Tunisia, Argentina, and India [3] . Emergence of NDM-1 has been considered as a global threat because bacteria which possess this metallo--lactamase are resistant to almost all -lactam antibiotics, aminoglycosides, fluoroquinolones, and other classes of antibiotics. The rapid emergence of NDM-1 may be due to transmissible plasmids which can spread among different isolates; subsequently, NDM-1 can spread throughout the world. The bla NDM-1 gene is carried on different plasmids and can harbour a large number of resistance genes such as KPC, OXA-48, and CTX-M-15 [4] . KPC-producing isolates of K. pneumoniae and other bacteria have spread rapidly throughout the world. KPCproducing K. pneumoniae isolates have been reported from 2 Scientifica Iran and mortality rate among patients with positive KPC was 33% [5] . The other reports have been described in other areas, including China, Demark, Greece, Hungary, Argentina, Brazil, Colombia, Finland, France, Germany, Italy, Sweden, Norway, Puerto Rico, and the United Kingdom [6] . KPC-producing strains typically possess ESBLs or Amp-C enzymes, which can hydrolyze carbapenems, penicillins, cephalosporins, and aztreonam [4] . In K. pneumoniae, two major porins, OmpK36 and OmpK35, are homologous to OmpF and OmpC, respectively. Clinically, most of the ESBLproducing K. pneumoniae strains express only OmpK36, whereas the majority of K. pneumoniae that do not produce ESBLs express both OmpK36 and OmpK35. The absence of OmpK35 may be one of the factors contributing to the antibiotic resistance of ESBL-producing K. pneumoniae. Reports also revealed that OmpK36 may play an important role in carbapenem resistance of K. pneumoniae strains that produce ESBL or Amp-C-type -lactamases [7] . The aims of this study were the phenotypic detection of -lactamases and OXA-48, NDM-1, and CTX-M-15 genes among K. pneumoniae strains isolated in Iran. The detection of outer membrane porins in ESBL-producing K. pneumoniae strains is also analysed. (GEN, 10 g ), amikacin (AK, 30 g)), tetracyclines (tetracycline (TE, 10 g)), fluoroquinolones (ciprofloxacin (CIP, 5 g)), inhibitors (trimethoprim-sulfamethoxazole (TS, 2.5 g)), fosfomycins (fosfomycin/trometamol (FOT, 200 g)), and tigecycline (TGC, 15 g) were used and Escherichia coli ATCC25922 was used as a control strain.
Materials and Methods

Minimum Inhibitory Concentration (MIC)
. Antimicrobial susceptibility was determined by broth microdilution method according to the guidelines of CLSI. Briefly, microbial inoculums in Mueller-Hinton broth were adjusted to final concentration of 0.5 on the McFarland scale and were diluted to 1 : 20. 10 microliters of each inoculum was added to wells containing 100-microliter Muller-Hinton broth and the following antibiotics: imipenem, meropenem, cefepime, ampicillin, piperacillin/tazobactam, cefotaxime, ceftriaxone, and ceftazidime (GLAXO England Co. and Himedia). After 24-hour incubation at 37 ∘ C microbial growth for each treatment was evaluated. Results are shown in Table 2 .
Phenotypic Detection of -Lactamases.
Combination disk diffusion test (CDDT) was performed for presumptive identification of MBLs by imipenem, meropenem, doripenem, and ertapenem (Mast Group, Merseyside, UK) alone and in combination with EDTA [9] . Detection of ESBLs was tested for all the isolates by combination disk diffusion test (CDDT) containing ceftazidime (CAZ) and cefotaxime (CTX) with CAZ 30 g + CA 10 g and CTX 30 g + CA 10 g per disc (Mast Group, Merseyside, UK). The zones of inhibition were compared for the CTX, CAZ discs with that of the CAZ 30 g + clavulanic acid (CA) 10 g and CTX 30 g + CA 10 g disc. An increase in zone diameter of ≥5 mm in the presence of clavulanic acid was interpreted positive for the presence of ESBL in the test organism. Escherichia coli ATCC25922 and K. pneumoniae ATCC700603 were used as negative and positive controls for ESBL production, respectively. Presumptive identification of KPC enzyme was performed for all the K. pneumoniae isolates by modified Hodge test [7] . Amp-C was detected using the D69C AmpC Detection kit developed by Mast Group [10] . 2.6. Sequencing. The PCR purification kit (Bioneer Company, Korea) was used to purify PCR products. Sequencing of forward strand was also performed by Bioneer Company (Korea). BLAST in NCBI, Chromas 1.45, and MEGA-4 software were used to analyse the nucleotide sequences.
Detection of Resistance
Outer Membrane Porins Analysis.
The outer membrane porins OmpK35 and OmpK36 were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) using membrane extracts. PCR and sequencing methods were carried out to confirm the presence of the outer membrane genes [11] . Hospital. Number and percent of -lactamases present in K. pneumoniae isolates are shown in 
Discussion
Recent studies indicated that emergence of antibioticresistant clinical isolates and multidrug-resistant K. pneumoniae strains have been increased among patients in Iran [12] . 
The lowest rates of resistance in isolates were observed for fosfomycin 3 (3.6%), tigecycline 5 (6.02%), amikacin 12 (14.4%), ertapenem 21 (25.3%), doripenem 20 (24%), meropenem 20 (24%), imipenem 20 (24%), and piperacillin/tazobactam 22 (26.5%). The highest rates of resistance observed belonged to ampicillin 65 (78.3%), cefpodoxime 57 (68.6%), cefotaxime 50 (60.2%), piperacillin 50 (60.2%), ceftriaxone 49 (59%), aztreonam 49 (59%), ciprofloxacin 46 (55.5%), and ceftazidime 46 (55.5%). So, the best coverage against the study isolates was obtained with tigecycline and fosfomycin. Another concerned problem is related to their multidrug resistance which restricts the treatment procedure. Resistance to antibiotics is related to various enzymes that are produced, including ESBLs, MBLs, KPC, and Amp-C which belong to Ambler A, B, and C groups [13, 14] . The high rate of ESBLs among hospitalized patients is a global problem. The prevalence of ESBL-producing isolates of K. pneumoniae varies in different countries [15] . In this study, 48 (57.5%) of K. pneumoniae were identified as ESBL producers by phenotypic tests, which was less than Ahangarzadeh et al. 's study 124 (83.2%) and Feizabadi et al. 's study 75 (72.1%) in Iran [16, 17] and another study in Turkey (60%) and was less than Latin America (45.4%), Western Pacific (24.6%), and Europe (22.6%) [15] . The high rate of ESBL prevalence in Iran and its widespread dissemination is a cause of worry.In Spain, the results revealed that 133 adults and 29 pediatric patients were infected with ESBL-producing K. pneumoniae [18] . In this study, 24 adults and 33 pediatric patients were infected with ESBL-producing K. pneumoniae. The wide use of drugs might facilitate the spread of antibiotic resistance; thus control oflactamases especially ESBL-producing K. pneumoniae within infant units should be considered as precedence. Resistance to carbapenem is related to MBLs and KPC -lactamases which belong to Ambler A and B groups [19] . In this study by using the CDDT method, 3 (3.5%) K. pneumoniae isolates were identified as MBL producers. Also, 5 (6%) of K. pneumoniae isolates were identified as KPC producers by MHT, which was less than Shahcheraghi et al. 's study 11 (47.8%) in Iran and Chen et. al's study 75 (72.1%) in China [6, 20] . The prevalence of Amp-C in Iran and worldwide is unknown, due to laboratories having a problem in accurately detecting this resistance mechanism. In this study by using the D69C AmpC Detection kit, 23 (28%) K. pneumoniae isolates were identified as Amp-C producers. RodriguezBano et al. showed that 100 patients were infected with plasmid-mediated Amp-C -lactamases including 17 Amp-C-producing K. pneumoniae [21] . In another study, [26] . In a recent study, two isolates harboured both OXA-48 and CTX-M-15. K. pneumoniae produces two major porins, OmpK35 and OmpK36. However, most ESBL-expressing K. pneumoniae clinical isolates produce only OmpK36 porin [27] . OmpK35 and OmpK36 provide a channel that allows a wide range of antibiotics to penetrate to cell wall. We have reported the existence of two major porins, OmpK36 and OmpK35, in K. pneumoniae. OmpK35 was detected in 30 (62.5%) of the 48 ESBL-producing isolates while OmpK36 was found in 35 (72.91%) of the 48 ESBLproducing isolates. Loss of this porin may be one of the factors contributing to antimicrobial resistance among ESBLproducing K. pneumoniae and may favour the selection of additional mechanisms of resistance. Microbiology laboratories must be able to identify resistant bacteria in a timely suitable manner, especially those that are falsely susceptible in vitro to antibiotics that may be considered for therapy of infected adults and infants. Bacteriological excellence is needed more than ever, and it is vital that ESBLs enzymes, Amp-C, and carbapenemases be promptly and accurately detected.
